UIM6:F:F-UBS ETF SICAV - MSCI USA UCITS ETF (EUR)

ETF | Others |

Last Closing

USD 485.32

Change

+6.68 (+1.40)%

Market Cap

USD 0.62B

Volume

N/A

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-09-12 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
PRAJ:F Amundi Index Solutions - Amund..

-0.28 (-1.06%)

USD 139.20B
UIM5:F UBS (Lux) Fund Solutions - MSC..

-0.35 (-0.70%)

USD 108.20B
SXR8:F iShares Core S&P 500 UCITS ETF..

N/A

USD 93.32B
ZPDJ:F SPDR® MSCI Japan UCITS ETF

-0.28 (-0.51%)

USD 86.92B
SXRZ:F iShares VII PLC - iShares Nikk..

N/A

USD 53.24B
VUAA:F Vanguard S&P 500 UCITS Acc

+0.23 (+0.24%)

USD 51.63B
VUSA:F Vanguard Funds Public Limited ..

N/A

USD 51.63B
XDNY:F Xtrackers MSCI Japan ESG Scree..

N/A

USD 51.19B
XJSE:F Xtrackers II - Japan Governmen..

N/A

USD 41.09B
0ZC:F Zscaler Inc

+0.42 (+0.28%)

USD 37.92B

ETFs Containing UIM6:F

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 16.19% 86% B+ 75% C
Dividend Return N/A N/A N/A N/A N/A
Total Return 16.19% 83% B 67% D+
Trailing 12 Months  
Capital Gain 23.99% 82% B 76% C+
Dividend Return N/A N/A N/A N/A N/A
Total Return 23.99% 79% B- 67% D+
Trailing 5 Years  
Capital Gain 86.21% 95% A 85% B
Dividend Return N/A N/A N/A N/A N/A
Total Return 86.21% 95% A 72% C
Average Annual (5 Year Horizon)  
Capital Gain 14.49% 89% A- 78% C+
Dividend Return 14.49% 87% B+ 71% C-
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 15.05% 41% F 76% C+
Risk Adjusted Return 96.33% 96% N/A 95% A
Market Capitalization 0.62B 64% D 52% F

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:
High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.